mevalonic acid has been researched along with Stomach Neoplasms in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (80.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, K; Lin, J; Liu, G; Lv, G; Qiu, L; Wang, S; Wang, W; Xie, M; Yang, H; Zhao, X | 1 |
Chang, WC; Chen, L; Cheng, BH; Cheng, WC; Hung, YC; Jeng, LB; Ju, LJ; Ma, WL; Ou, YJ; Yang, MD | 1 |
Corcos, L; Le Jossic-Corcos, C | 1 |
Kang, WK; Kim, J; Lee, I; Lim, T | 1 |
Kim, BS; Kim, TS; Min, JS; Noh, SH; Rha, SY; Roh, JK; Yoo, NC | 1 |
2 review(s) available for mevalonic acid and Stomach Neoplasms
Article | Year |
---|---|
Mitochondrial Acetyl-CoA Synthetase 3 is Biosignature of Gastric Cancer Progression.
Topics: Acetate-CoA Ligase; Apoptosis; Biomarkers; CCAAT-Enhancer-Binding Proteins; Cholesterol; Databases, Genetic; Disease Progression; Energy Metabolism; Humans; Metabolic Networks and Pathways; Mevalonic Acid; Mitochondria; Models, Biological; Neoplasm Staging; Prognosis; Proportional Hazards Models; Stomach Neoplasms; Stress, Physiological | 2018 |
Statins: perspectives in cancer therapeutics.
Topics: Colorectal Neoplasms; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Neoplasms; Mevalonic Acid; Pancreatic Neoplasms; Stomach Neoplasms | 2013 |
3 other study(ies) available for mevalonic acid and Stomach Neoplasms
Article | Year |
---|---|
Insights into the mevalonate pathway in the anticancer effect of a platinum complex on human gastric cancer cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Humans; Imidazoles; Mevalonic Acid; Monomeric GTP-Binding Proteins; Organoplatinum Compounds; Protein Prenylation; Signal Transduction; Stomach Neoplasms | 2017 |
Synergistic Effect of Simvastatin Plus Radiation in Gastric Cancer and Colorectal Cancer: Implications of BIRC5 and Connective Tissue Growth Factor.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Chemoradiotherapy; Colorectal Neoplasms; Combined Modality Therapy; Connective Tissue Growth Factor; Female; Fluorouracil; Gene Knockdown Techniques; Humans; Inhibitor of Apoptosis Proteins; Mevalonic Acid; Mice, Inbred BALB C; Microarray Analysis; Radiation-Sensitizing Agents; RNA, Small Interfering; Simvastatin; Stomach Neoplasms; Survivin; Xenograft Model Antitumor Assays | 2015 |
Modulation of biological phenotypes for tumor growth and metastasis by target-specific biological inhibitors in gastric cancer.
Topics: Anticoagulants; Antineoplastic Agents; Carrier Proteins; Cell Adhesion; Cell Division; Cell Movement; Cytokines; Doxorubicin; Drug Synergism; Gelatinases; Humans; Lovastatin; Matrix Metalloproteinase 2; Metalloendopeptidases; Mevalonic Acid; Midkine; Neoplasm Metastasis; Pentosan Sulfuric Polyester; Peptide Hydrolases; Phenotype; Plasminogen Activator Inhibitor 1; Protease Inhibitors; Stomach Neoplasms; Tissue Inhibitor of Metalloproteinase-2; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator | 1999 |